Terms of Use and Privacy Policy of the «RECIGAR» Mobile Application

1. This document (“Terms”) outlines the terms of use and data processing for the RECIGAR mobile application (hereinafter referred to as the “Application”), owned by UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES SA (hereinafter referred to as the “Publisher”), with its registered office at Kifissia, Attica, 14th km of the Athens – Lamias National Road, P.C.14564, VAT number 094320634, Tax Office KEFODE Attica, General Commercial Registry (GEMI) no. 000760401000, legally represented, with the e-mail unipharma@uni-pharma.gr.

2. By creating an account or using the Application, User confirms that he/she accepts these Terms and also confirms that User is over 18 years of age. A user of the Application is defined as any individual who downloads and installs the Application on their mobile device (hereinafter referred to as the “User”). Since it is not technically possible to effectively check User’s age in all circumstances, in the event that the submission of personal information concerning minors is reported and verified, Publisher shall to immediately delete all relevant information. This deletion applies without prejudice to the need to maintain the data in case of establishing, exercising or supporting Publisher’s legal claims.

3. The Application is intended for adult users seeking to quit smoking with the aid of the RECIGAR medication. The Application offers motivational support in their journey to overcome smoking addiction. Publisher does not provide services under the Application. User may not use the Application while using any other product other than RECIGAR as the information may be different.

4. The Publisher grants User a limited, non – exclusive, non- transferrable and revocable license to use, only for personal and not commercial purposes and does not grant any ownership rights on the Application. The User acknowledges and agrees that the Application belongs to the Publisher and is protected under applicable copyright, trademark, trade secret and other intellectual property laws. Nothing in these Terms gives User the right to use Publisher’s and/or Application’s name, trademarks, logos, domain names and all rights, title and interest remain with Publisher. All the Application content including but not limited to text , software, scripts, code, designs, graphics, photos, sounds, music, videos, features etc is Publisher’s intellectual property, all rights reserved.

5. User agrees not to reverse engineer, decompile, disassemble or make any attempts to discover the source code or algorithms of the Application, not to modify or disable any features, not to create any derivative works based on the Application, rent, lease, lend the Application use, infringe Publisher’s intellectual property rights or any third party rights using the Application, use the Application in any way that violates these Terms or any laws, use the Application in any fraudulent, malicious way for example to introduce viruses, harmful data or in any way that may be contrary to Publisher’s interests, or use the Application in any way that could damage, disable, overburden, impair or compromise Publisher’s systems or security or interfere with other Users of the Application.

6. Before using the Application, the User is advised to read the RECIGAR “Package leaflet” document, which includes details on indications, contraindications, potential side effects, dosage, and proper use and the User should consult a doctor or a pharmacist if User needs more information or advice.

7. By accepting these Terms, the User acknowledges that the Application does not lead to or warrants success of the smoking cessation or of process. The Publisher emphasizes that the information provided within the Application is for informational purposes only and does not constitute medical advice, consultation, or recommendations. The content of the Application cannot replace consultation with a healthcare provider, including physicians and pharmacists. The Ministry of Health and the National Medicine Organization advise: “Read the drug’s instructions for use carefully. Consult with your doctor or pharmacist”. Application is not intended for use in the diagnosis, prevention or treatment of any disease or other conditions and is not intended for use in the detection, diagnosis, monitoring, management or treatment of any medical condition, disease or vital physiological process or for the evaluation of health information. Any information found, acquired, or accessed through the Application is made available only for User’s convenience, and should not be treated as medical advice. User understands and agrees that any information obtained from the Application may not be suitable, accurate, complete, or reliable and that Publisher will not be held liable for any injuries, damages, losses, and/or costs associated with the Application, nor for the accuracy, timeliness, performance or reliability, error-free of the Application and/or any information found, acquired, or accessed through the Application. The Application does not generate any individual benefit for patients. Publisher has no liability for the data that User shall include in the Application and for any malfunction, delay, failure of any functionality. User is solely responsible for any damage or loss if User allows anyone that is not himself/herself to use or handle User’s device or his/her account. It is User’s responsibility to maintain the confidentiality and security of his/her device and account. Publisher is not liable for any losses or damages suffered due to lost, stolen, or damaged device.

8. The User may discontinue use of the Application at any time by uninstalling it according to his/her device’s instructions. Subscription and/or use of the Application is voluntary and free of charge.

9. A detailed description of the Application’s functionality can be found in Appendix 1 of this document. Publisher may change, add, suspend or remove features from the Application or suspend or terminate User’s right to use the Application, including access to the account or data in case of beach of these Terms or the Law and Publisher will not be liable towards the User or any third party for exercising such rights. User may terminate this Agreement at any time by deleting the Application and ceasing use of such.

10. Essential updates such as critical bugs fixes or security updates may be downloaded and installed automatically to protect users. For other updates the User retains control over whether to download such updates for the Application. Automatic updates are subject to the personal settings of the User’s device.

11. Please take the necessary time to read these Terms carefully. During use of the Application, statistics regarding usage and errors may be automatically collected and may be processed by the Publisher for marketing and statistical purposes. This data is anonymous and do not include any personal identifiers. The Application utilizes Google Analytics, an analytical tool managed by Google Inc. (based in the USA). Users can block Google Analytics from tracking their activity by installing a browser add-on that prevents Google Analytics from sharing such information. Detailed instructions can be found at support.google.com. The Application collects and processes personal data, i.e. information related to a natural person who is or can be identified from this information, regardless of whether the identification can be carried out directly or indirectly. Processing of this data means any work carried out in relation to this data, whether automated or not. Personal data includes, for example, information such as name, e-mail address or telephone number that can be used to identify a visitor in the Application. The Publisher lawfully processes the Personal data, as it collects and processes them exclusively for specified, explicit and legitimate purposes and only to the extent necessary for the realization of these purposes. The data it keeps is accurate and up to date to the extent these are updated by the data subjects, i.e. the natural persons to whom the data concern.

12. User may not provide personal data on behalf of a third party. The data controller is UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES SA (hereinafter referred to as the “Publisher”), with its registered office at Kifissia, Attica, 14th km of the Athens – Lamias National Road, P.C.14564. The Publisher collects, processes and uses the personal data concerning the User, mainly when User downloads and uses the Application, exclusively for the following purposes, in particular for: a) monitoring the Application traffic b) improving the Application, c) complying with the obligations imposed on the data controller by the GDPR, d) the fulfillment of Publisher’s legal obligations and the raising of claims and e) the protection of the Publisher’s interests.

A) When downloading the Application, the User’s IP address (Internet Protocol address), the device ID or other device identifiers, the date, time, duration of the visit, the browser type, browser settings, user’ s place of origin and operating system are recorded. This technical information may, in individual cases, constitute personal data. Publisher limits the collection of data to the absolutely necessary, in order to achieve compliance with the data processing principle, pertaining to the minimization of data processing. As a rule, Publisher uses technical data, however, only to the extent that this is necessary for technical reasons, for the operation and protection of the Application against attacks and malicious use, as well as in pseudonymous or anonymous form for statistics purposes.

B) Publisher collects data for the specific purposes of processing the personal data, for which Users willingly provide Publisher with data, namely when Users include data during registration to or use of the Application, or User wish to contact Publisher the following information is collected and processed: Full name, email address, date of last visit, date of acceptance of these Terms, IP address, device ID, date of initiating RECIGAR use, number of dosage, date of use, time of notification, failure of smoking cessation process, motivation for smoking cessation, type (cigars, tobacco), quantity of cigars, potential savings from smoking cessation. User is informed that in the event of an acquisition of all or part of the Application by another company, Publisher will share information with that successor company. The criteria on which this is based are among others legal obligations, pending or potential disputes, intellectual property, proprietary rights, contractual obligations, filing. The Publisher retains the data for as long as necessary for the implementation of the specific purposes. Different retention periods for data may apply, depending on the purpose of the processing. When the storage period expires or when User deletes his/her account, the data is deleted accordingly. The Publisher may transmit the data to other companies of its Group, to affiliated companies within the European Economic Area, which will process the data on behalf of the Publisher as data controllers or data processors, exclusively and only for reasons mentioned in these Terms and ensuring data safety. Data recipients include IT system providers and subcontractors to the extent necessary for processing purposes.

The Publisher processes data mainly within the European Union (EU) and the European Economic Area (EEA). For transfers to countries not considered safe by the European Commission, should such transfers take place, suitable and proper safeguards for the protection of personal data are received, such as standard contractual clauses or other legal tools. The security of User’s personal data is a high priority for the Publisher. When transmitting the data, the Publisher takes all necessary security and confidentiality measures to ensure the highest possible level of security. Therefore, Publisher protects User’s data, stored with us, through technical and organizational measures to effectively prevent loss or unauthorized access or misuse of it by third parties. Specifically, Publisher’s employees, who process personal data, are committed to maintaining confidentiality. To protect the personal data, data is transmitted in encrypted form. To ensure the long-term protection of User’s data, the technical security measures are regularly monitored and, if necessary, adapted to the respective prevailing technology standards. Unfortunately, no system for transmitting or storing data is 100% guaranteed to be secure. The User by choosing that he/she agrees to these Terms he/she consents to the processing of his/her personal data andgives his/her consent to the processing of the data for the above specific purposes, and can at any time withdraw such consent, as well as exercise any of his/her legal rights, namely access such data and obtain a copy of it, correct inaccurate personal information, erase (forget) his/her data or restrict their processing. Data subjects have also the right to access, rectify, erase, or restrict the processing of their data, as well as the right to data portability, objection if they believe their data is being processed unlawfully. The Publisher responds to User’s requests without delay and in any case within one (1) month upon receiving each request, unless if due to the complexity of request or due to the multitude of requests, an extension of another (2) two months may be needed, within which Publisher will get back to User in which case Publisher will inform User within the month. If requests are manifestly unfounded or excessive, in particular due to their repetitive nature, the Publisher may either impose a reasonable fee, taking into account the administrative costs of providing the information or communicating and performing the requested action, or refuse to proceed with the request. User may sent inquiries regarding his/her personal data protection to: dataprivacy@uni-pharma.gr.

13. Publisher may change these Terms at any time and in the event of changes to this document, a new version of the Application will be made available in the Application. If User does not agree to the changes he/she can stop using the Application. By continuing to use the Application after the updated Terms become effective, User confirms that he/she understands and accepts the updated Terms. Information regarding any updates will be provided in the history version available in the Google Play and Apple Store.

14. The Application and its functionalities are provided “as is” and on an “as available” basis, without warranties of any kind, either express or implied and Publisher disclaims all warranties or other terms expressed, implied, or statutory, including, but not limited to, implied warranties or terms of merchantability, satisfactory quality, workmanlike effort, fitness for a particular purpose, reliability or availability, accuracy, lack of viruses, non-infringement of third party rights, or other violation of rights. No advice or information, whether oral or written, that may be obtained from Publisher, or its affiliates shall be deemed to alter Publisher’s disclaimer of warranty regarding the Application, or to create any warranty of any sort from Publisher. Without limiting the previous disclaimer, Publisher does not represent, warrant, or guarantee that the Application or the content therein will (i) operate in an uninterrupted, timely, secure, or error-free manner; (ii) will be free from all harmful components or errors; (iii) will be secure or immune (including the content delivered to the User or the information User provided) from unauthorized access; or (iv) will be accurate, complete, or reliable, that the quality will be satisfactory to User, or that errors will be corrected. The Application may contain links to Publisher’s websites, applications or other products or services of third parties (“third party services”). Publisher does not endorse, monitor, warrant, guarantee, or have any control over or assume responsibility for third-party services, advertisements, content, or any other product or services that may be advertised or offered by a third party on or through the Application or any third party links and such third parties have separate terms of use and policies for which Publisher is not responsible and User accesses such at its own risk. Publisher will not be liable for any direct or indirect, incidental, special, consequential, or punitive damages, or any loss of profit, revenue, goodwill, business, opportunity, or data or any other intangible losses. The foregoing limitation applies whether such damages arise out of breach of contract, tort (including negligence), or otherwise and regardless of whether such damages were foreseeable or the Publisher was advised of the possibility of such damages.

15. User agrees to indemnify, defend, and hold harmless Publisher, its licensors, agents, and all officers, directors, and employees from any and all third party claims, actions, losses, damages, liabilities, judgments, grants, costs, and expenses (including reasonable attorneys’ fees) arising from: (i) User’s use of the Application or use by any person that User’s allow to use that is not in accordance with these Terms, (ii) any breach of this Terms by User or by any person that User’s allow to use the Application, or (iii) any violation of any laws or regulations or the rights of any third party by User or by any person that User allows to use the Application.

16. This Agreement and the use of the Application by the User does not and shall not be construed as creating any relationship, joint venture, partnership, employment or agency in any way and of any kind between User and Publisher.

17. This Agreement is governed by the applicable laws of Greece and the competent courts of Athens, Greece have jurisdiction.

18. These Terms its appendix and all other terms and policies referred to herein as may be valid from time to time constitute the entire legal agreement between User and Publisher and supersede any prior or contemporaneous oral or written communications, proposal or representation with respect to the Application and any subject matter covered by these Terms. If Publisher does not exercise or enforce any rights or remedy which is contained in the Terms or that has at law, such omission will not be taken to be a waiver of any or all such rights and remedies, and that those rights and remedies will remain available to Publisher. If any court of law with competent jurisdiction rules that any provision of these Terms is invalid, such provision will be removed from the Terms without affecting the rest of the Terms. The remaining provisions of the Terms will continue to be valid and enforceable.

19. All communication, notices etc will be made electronically, including e-mail, pop-up, push notification or text. For questions regarding the functionality of the Application, Users may contact Pubisher via email at: unipharma@uni-pharma.gr.

Date of last revision: Athens, 27 March 2025

Appendix No. 1 to the Terms of Use and Privacy Policy of the “RECIGAR” Mobile Application

Description of the Application’s Functionality

1. The Application is available for download free of charge from the following platforms:

a) Google Play

b) Apple Store

Any costs associated with data transmission, use of platforms and downloading are borne by the User and are subject to the terms and rates of their respective service provider.

To download and use the Application, the User must have a functional mobile device that meets the following technical requirements:

a) For Google Play version: system version 6.0 or higher, SDK 23 or higher.

b) For Apple Store version: iOS version 12 or higher.

2. Installation of the Application is contingent upon acceptance of these Terms, which is presented to the User during installation. This document is also available within the Application under the “Settings” tab.

3. Account

By creating an account User agrees that he/she will provide accurate and complete information when creating the account and update information if there are any changes.

The User Registration Flow is as follows:

1. The User opens the application. The welcome screen appears.

2. By hitting the “Terms of Use” button, User is redirected to the Terms of use screen, image.

3. By hitting the “I’m Informed” button User is redirected to the next screen “What brings you to the RECIGAR App?”.

4. By hitting the button “I want to quit nicotine with RECIGAR” or “I’m thinking about quitting nicotine”

User is redirected to the screen where the Application asks the User if he/she wants to log in or create an account.

A. If the User chooses to register:

1. He/she fills in his/her details in the registration form,

2. An email is sent with the email confirmation code,

3. Fills in the confirmation code

4. Proceeds to the Engagement Flow

B. If the User chooses to log in, fills in his/her details (email, password), and depending on the case, the Application redirects User

– to the Application dashboard

– to the engagement flow (if for some reason he/she had not completed it)

– if he/she hasn’t used the Application for a long time, the Application asks if he/she has started consuming nicotine again in order to redirect him/her to the engagement flow.

4. First Launch

Upon the initial launch, the User is prompted to provide data necessary for the proper functioning and personalization of the Application:

1) Confirmation of having read the information regarding the RECIGAR drug, as well as the Terms and Conditions and Privacy Policy of the RECIGAR Application.

2) Responses to initial questions:

– The date since the user stopped smoking,

– The date since the user started taking the RECIGAR drug,

– The preferred time for taking the first dose of RECIGAR,

– The user’s daily expenditure on cigarettes prior to quitting smoking.

5. Alerts

The Application features a reminder system for taking the prescribed doses of RECIGAR on specified days and at set times. The dosing schedule follows the RECIGAR Summary of Product Characteristics (SmPC). Reminders are sent in the form of notifications on the user’s mobile device. Clicking on the notification redirects the user to the Application.

6. Motivation

a) Users can earn achievements digital badges for consecutive non-smoking days, accompanied by motivational messages that recognize their progress.

b) Achievements will be displayed on the Application’s screen when it is launched, provided the user has earned a new achievement.

c) Statistics feature displays the following:

– Number of days the user has been taking RECIGAR,

– Number of doses taken,

– Number of days without smoking,

– Total amount of money saved since quitting smoking.

d) Users can edit their settings within the Application.

7. Additional Notifications

The Application also sends additional notifications related to motivation, diet, and physical activity to support the User’s journey.

8. Goal Setting

The user can specify a savings goal (e.g., what they are saving for) as motivation for quitting smoking.